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The oncogenic potential of a combination of hyperthermia and
chemotherapy agents
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Summary The modulating effect of 43°C hyperthermia on the induction of oncogenic transformation by the
antineoplastic agents, actinomycin D, mitomycin C, and 1,3-bis(2-chloroethyl)-l-nitrosourea (BCNU) was
examined using the C3H lOTl/2 cell line. For any given level of cytotoxicity, cells exposed to the three
chemotherapy agents at 37°C showed similar frequencies of transformation. Transformation frequencies
induced by all three drugs were reduced by hyperthermia. The reduction was most pronounced for cells
exposed to BCNU, and to a lesser extent, by cells exposed to actinomycin D and mitomycin C. The
modulating effects of heat on drug-induced transformation incidence appeared to be independent of whether
application of heat and drug was concurrent or sequential.
Hyperthermia enhances the cytotoxicity of some, but not all,
chemotherapy agents (Bull, 1984; Hall & Roizin-Towle,
1984). The magnitude of the enhancement is quite variable
for different drugs. The rationale for combining heat and
drugs is that local hyperthermia 'targets' the action of the
chemotherapy agents, since it enhances cell killing within
the region of elevated temperature, which includes the
tumour, without affecting systemic toxicity. While the
potential for success is good, combinations of hyperthermia
and chemotherapy agents have not been exploited widely in
the clinic. As more and more chemotherapy agents are used
in the treatment of cancer, concern for the potential
induction of second malignancies from the anticancer treat-
ment becomes increasingly relevant.
In the present report, three widely different drugs were
tested in combination with hyperthermia, delivered either
concomitantly or sequentially. A well-tried in vitro assay for
oncogenic transformation was used to determine whether the
change in cell killing often associated with a combination of
heat and drugs is also paralleled by a change in
oncogenicity.
Materials and methods
Cell culture and transformation assay
The C3H 10T1/2 mouse embryo fibroblast cell line
developed by Reznikoff et al. (1973a) was used throughout
this investigation. The cell line has been well characterized.
Cell cultures were grown at 37°C in humidified incubators
with 5% CO2 in air. Stock cell cultures between passages 9
and 12 were trypsinized and 1.5 x 101 cells were plated into
25-cm2 flasks 48 h before heat and chemical treatments.
Immediately after treatment, the subconfluent cells were
trypsinized and replated into 100-mm diameter plastic petri
dishes at cell concentrations estimated to produce 300 viable
cells 'for determination of transformation incidence or 30
viable cells for the cell survival assay. Cells were grown in
Eagle's basal medium supplemented with 10% heat-
inactivated foetal calf serum and 25 ugml- 1 gentamycin.
Serum lots were examined and chosen for use if the trans-
formation frequency was consistent with frequencies from
previous serum lots. For the transformation assay, medium
was changed regularly for the 6-week incubation period.
Cells were fixed with formalin and stained with giemsa. Cells
plated for cell survival determinations were incubated for 2
weeks without medium change before being fixed and
stained. Transformed foci types II and III as described by
Reznikoff et al. (1973b) were scored to calculate the
frequency of transformation in controls and treatment
groups. Cell survival was determined by the colony assay
method.
Chemicals
Actinomycin D (actD) and mitomycin C (MMC) were
obtained from Sigma Chemical Company (St Louis, MO).
1.3-bis(2-chloroethyl)-1-nitrosourea (BCNU) was kindly
supplied by the Drug Synthesis and Chemistry Branch of the
National Cancer Institute. ActD and BCNU were dissolved
in ethyl alcohol with the final concentration of ethyl alcohol
in the medium at less than 0.08%. In previous studies,
concentrations of alcohol of up to 1% showed no ability to
modulate either oncogenic transformation or cell survival.
MMC was initially dissolved in Hank's Balanced Salt
Solution. Chemicals were prepared fresh, immediately before
cell treatments. After exposure to chemicals, cells were rinsed
twice with Hank's Balanced Salt Solution.
Hyperthermia treatment
All heat treatments were for 1 h and were accomplished by
immersion of parafilm-sealed tissue culture flasks in a water
bath controlled at a temperature of 43°C+0.05°C. Three
different sequences of heat and drug were used: (1) heat
treatment, followed by exposure to drug at 370 for 1 h, (2)
concurrent exposure to drug and heat at 43°C for 1 h; (3)
exposure to drugs at 370C for h, followed by heat
treatment. Medium pH was checked before and after
treatment, and was found to remain constant during
treatment when culture flasks were purged with 5% C02-
95% air prior to immersion in the water bath.
Results
Cells treated with actD, either alone or in combination with
heat (43°C), showed a survival response with increasing dose
that is concave upwards (Figure 1). Heat treatments, either
concurrently or sequentially, were found to reduce cell killing
to a greater extent than would be predicted if each agent
acted independently. On the contrary, heat potentiated cell
killing by BCNU in a more than additive fashion. The
shoulder of the survival curve was reduced compared to cells
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Figure 1 Dose-response curves of C3H 10TI/2 cells treated with
actD for 1 h either alone (*) or in combination with 43°C for
1 h: concurrent exposure (0), heat followed by actD (A), actD
followed by heat (-). Dashed line shows the theoretical curve if
the effects of heat and actD were purely additive. Error bars
represent + I s.d. from 5 experiments.
exposed to BCNU alone, while the slope remained
unchanged (Figure 2). It is noteworthy that, in addition to
concurrent exposure to BCNU and heat, enhancement of cell
killing also occured in sequential exposures of heat and drug.
This is not the case for cells exposed to the alkylating
agent MMC and heat. Only concurrent exposure to MMC
and heat resulted in an enhancement of drug-induced killing
by heat in a more than additive fashion (Figure 3). Survival
of cells exposed sequentially to MMC and heat is predictable
assuming independent cell killing of MMC and heat.
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Figure 2 Dose-response survival curves of C3H 1OTI/2 cells
treated with BCNU for 1 h either alone or in combination with
43°C for 1 h. Symbols are the same as in Figure 1.
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Figure 3 Dose-response survival curves of C3H lOT1/2 cells
treated with MMC for 1 h either alone or in combination with
43°C for 1 h. Symbols are the same as in Figure 1.
All chemicals tested in the experiment indicated induced
cellular transformation in a dose-dependent manner.
Although actD, BCNU, and MMC induce cell killing and
transformation at different dose-dependent rates, all three
chemicals resulted in similar transformation frequencies for
the same level of cell killing (Figure 4). The differences
observed at low transformation frequencies may have been
due to the variability of the spontaneous transformation
frequency. Heat treatment, regardless of the treatment
sequence, was found markedly to reduce transformation
induced by actD (Figure 5; Table I), as well as cell killing
(see Figure 8, panel A). The reduction of transformation in
cells exposed to heat and BCNU was not significant. BCNU
cell killing was enhanced by heat (Figure 6; Table II). In
addition, the effect of treatment sequence with BCNU and
heat on transformation incidence was not observed, while
concurrent exposure had higher cell killing than that of cells
exposed sequentially. As a result, there was no correlation
between cell killing and transformation incidence of cells
exposed to heat and BCNU (see Figure 8, panel B).
MMC and BCNU are both alkylating agents. However,
the effect of heat on MMC-induced transformation appears
to be different from the case of BCNU. The transformation
incidence by MMC and heat, though not statistically signifi-
cant from MMC alone, varied with the treatment sequence;
concurrent exposure appears to enhance transformation, but
sequential exposure reduces transformation (Figure 7; Table
III). Since concurrent exposure to MMC and heat enhanced
cell killing to a greater extent than transformation induction,
the transformation frequency for cells exposed to either
concurrent or sequential exposures were similar (Figure 8,
panel C).
Discussion
The effect of hyperthermia on cytotoxicity of the three drugs
studied was dramatically different. In the case of actD,
adding heat to the drug resulted in less cellular cytotoxicity
than would be expected if the lethal effects of heat and drug
were simply additive. This was true whether the heat
treatment was sequential or concomitant. In the case of
BCNU, however, heat produced a supra-additive effect when
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Figure 4 Transformation frequency versus surviving fraction of
C3H lOTl/2 cells treated with actD, BCNU, or MMC for h.
Shaded area shows the spontaneous transformation frequency.
Error bars represent + 1 s.d. from 5 experiments.
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Figure 5 Dose-transformation frequency of C3H IOT1/2 cells
treated with act D for 1 h either alone or in combination with
43°C for 1 h. Symbols are the same as in Figure 1. Shaded area
shows the level of the spontaneous transformation frequency.
cells were exposed to heat and drug. The greatest supra-
additivity was evident when the drug and hyperthermia were
applied concomitantly, but there was also a substantial
supra-additive effect even when the heat was delivered
sequentially. The situation with MMC was different from
either act D or BCNU; if heat was applied concurrently with
drug, a supra-additive effect was observed. However, if heat
was added sequentially, either immediately before or after
exposure to the drug, the action of the combined treatment
was simply the additive effects of the two agents acting
independently.
The results of the transformation studies performed in
parallel with the cell lethality studies are also quite
complicated. In the case of actD, the concentration-
dependent induction of transformation produced by the
chemotherapy agent was essentially completely removed by
the addition of heat, whether hyperthermia was administered
concomitantly or sequentially. In the case of BCNU, the
addition of heat tended to reduce, but did not eliminate, the
number of drug-induced transformants at all concentrations
examined. The interaction of drug and heat was even more
complicated in the case of MMC since concomitant exposure
to heat elevated the incidence of transformation produced by
a given drug concentration, while sequential heat treatment
slightly reduced the transformation incidence.
Perhaps the most informative analysis of the data is the
plot of transformation incidence per surviving cell as a
function of surviving fraction. This method of analysis gives
a picture of the oncogenic potential of a given treatment
schedule, whether the treatment consisted of exposing cells to
drug alone or drug in combination with hyperthermia, in
relation to the cytotoxic action of that same combination of
therapies. Figure 4 shows the transformation incidence as a
function of surviving fraction for the three drugs
investigated. It is interesting to note that over two decades of
survival, the transformation incidence as a function of
surviving fraction is virtually indistinguishable for the three
chemotherapy agents. It appears, therefore, that with drug
alone, a given level of cytotoxicity is associated inevitably
with a given transformation frequency. Figure 8 compares
the transformation frequency as a function of surviving
fraction for the three drugs with the various combinations of
hyperthermia. At first glance, this figure suggests that for a
given level of cell killing, the addition of hyperthermia
reduces the transformation incidence in every case. This
effect is most dramatic for BCNU, and applies to a lesser
extent with actD and MMC. When compared in this way,
as a function of surviving fraction, it seems to make very
little difference whether heat is delivered concurrently or
sequentially.
It is interesting to speculate on some of the possible
mechanisms involved. First, heat reduces the transformation
incidence produced by a chemical (Hall & Hei, 1985) or
indeed, as previously reported, by radiation (Harisiadis et
al., 1980). The most likely mechanism is that the reduction
in transformation is a consequence of the inhibition of
protein synthesis by heat. This possibility is supported by the
observations of Hahn and Shiu (1985), that protein synthesis
is inhibited by heat; and also from the work of Kennedy
(1982), who showed that X-ray transformation incidence is
reduced by the addition of cyclohexamide, a known inhibitor
of protein synthesis.
A broad conclusion with many practical implications may
be inferred from these data. The addition of hyperthermia
with any of the three chemotherapy agents tested results in a
lower oncogenic potential, for a given measure of cyto-
toxicity, than that attained with the drugs alone. Further, the
degree by which drug-induced transformation is reduced is
somewhat independent of whether the application of heat
and drug is concurrent or sequential. Thereby a treatment
strategy of combination therapy with heat and chemo-
therapeutic agents may be advantageous not only for the
treatment of primary cancers, but also may result in a lower
risk of treatment-induced secondary cancers.
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Table I Modulation of actinomycin D (1.0pgml 1, for 1 h) induced transformation by heat (43°C)
Number of
transformed
Average Average Number colonies Transformants
surviving surviving of ( x 10-4) per
fraction cells/dish dishes Type II Type III clonogenic cell
ActD alone 0.108 274 349 7 23 3.13
Sequential
exposure to actD
and then 43°C 0.234 262 283 6 3 1.21
Concurrent
exposure to actD,
430C 0.878 430 345 5 7 0.81
Sequential
exposure to 43°C
and then actD 0.207 405 256 6 3 0.87
Control 0.357a 298 230 2 0 0.29
Heat control 0.403 313 181 2 1 0.53
aPlating efficiency; Data pooled from 5 experiments.
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Figure 6 Dose-transformation frequency of C3H 1OTI/2 cells
treated with BCNU for 1 h either alone or in combination with
43°C for I h. Symbols are the same as in Figure 1. Shaded area
shows the level of the spontaneous transformation frequency.
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Figure 7 Dose-transformation frequency of C3H IOTI/2 cells
treated with MMC for 1 h either alone or in combination with
43°C for 1 h. Symbols are the same as in Figure 1. Shaded area
shows the level of the spontaneous transformation frequency.
Table II Modulation of BCNU (8.0pgmg 1, for 1 h) induced transformation by heat (43°C)
Number of
transformed
Average Average Number colonies Transformants
surviving surviving of ( x 10-4) per
fraction cells/dish dishes Type II Type III clonogenic cell
BCNU alone 0.65 265 457 6 19 2.04
Sequential
exposure to BCNU
and then 43°C 0.12 254 240 2 8 1.64
Concurrent
exposure to BCNU,
430C 0.026 188 370 6 2 1.15
Sequential
exposure to 430C
and then BCNU 0.14 445 315 13 3 1.14
Control 0.42a 352 110 1 1 0.52
Heat control 0.36 328 127 0 1 0.24
aPlating efficiency; Data pooled from 5 experiments.
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Figure 8 Transformation frequency as a function of surviving fraction of C3H lOT1/2 cells treated with actD, BCNU, or MMC
for 1 h either alone or in combination with 43°C heat for 1 h. Symbols are the same as in Figure 1. Shaded area shows the level of
the spontaneous transformation frequency.
Table III Modulation of mitomycin C (0.3 ugml-1, for 1 h) induced transformation by heat (43°C)
Number of
transformed
Average Average Number colonies Transformants
surviving surviving of (x 10-4) per
fraction cells/dish dishes Type II Type III clonogenic cell
MMC alone 0.48 427 428 14 12 1.42
Sequential
exposure to MMC
and then 43°C 0.29 394 314 3 6 0.73
Concurrent
exposure to MMC,
430C 0.04 352 353 10 20 2.41
Sequential
exposure to 43°C
and then MMC 0.20 328 353 9 4 1.12
Control 0.39a 349 211 1 0 0.14
Heat control 0.47 396 228 3 0 0.33
aPlating efficiency; Data pooled from 5 experiments.
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